v3.25.3

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 76,549	$ 70,905
Restricted cash	261	257
Short-term marketable securities	0	30,577
Accounts receivable, net	13,797	13,120
Inventory	16,248	16,915
Prepaid expenses and other current assets	4,380	4,474
Total current assets	111,235	136,248
Long-term inventory	2,474	1,681
Property and equipment, net	2,443	2,907
Goodwill	2,333	2,333
Right of use assets	18,279	18,545
Other long-term assets	1,517	1,136
Total assets	138,281	162,850
Current liabilities
Accounts payable	6,420	3,827
Accrued liabilities	14,936	16,472
Income taxes payable	189	49
Deferred revenue	92	135
Short-term debt	105	3,176
Current lease liabilities	1,136	778
Total current liabilities	22,878	24,437
Deferred tax liability	47	87
Long-term lease liabilities	18,298	18,515
Long-term debt	37,025	34,002
Total liabilities	78,248	77,041
Commitments and contingencies (Note 8)
Stockholders’ equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2025 and December 31, 2024	0	0
Common stock, $0.001 par value, 200,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 41,246,534 shares issued and outstanding as of September 30, 2025 and 39,785,969 shares issued and outstanding as of December 31, 2024	41	40
Additional paid-in capital	568,887	551,211
Accumulated other comprehensive income	2,238	2,113
Accumulated deficit	(511,133)	(467,555)
Total stockholders’ equity	60,033	85,809
Total liabilities and stockholders’ equity	$ 138,281	$ 162,850

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Pulmonx Corp 10-Q